Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-1-14
pubmed:abstractText
Membrane phospholipids are susceptible to oxidation, which is involved in various pathological processes such as inflammation, atherogenesis, neurodegeneration, and aging. One enzyme that may help to remove oxidized phospholipids from cells is intracellular type II platelet-activating factor acetylhydrolase (PAF-AH (II)), which hydrolyzes oxidatively fragmented fatty acyl chains attached to phospholipids. Overexpression of PAF-AH (II) in cells or tissues was previously shown to suppress oxidative stress-induced cell death. In this study we investigated the functions of PAF-AH (II) by generating PAF-AH (II)-deficient (Pafah2(-/-)) mice. PAF-AH (II) was predominantly expressed in epithelial cells such as kidney proximal and distal tubules, intestinal column epithelium, and hepatocytes. Although PAF-AH activity was almost abolished in the liver and kidney of Pafah2(-/-) mice, Pafah2(-/-) mice developed normally and were phenotypically indistinguishable from wild-type mice. However, mouse embryonic fibroblasts derived from Pafah2(-/-) mice were more sensitive to tert-butylhydroperoxide treatment than those derived from wild-type mice. When carbon tetrachloride (CCl(4)) was injected into mice, Pafah2(-/-) mice showed a delay in hepatic injury recovery. Moreover, after CCl(4) administration, liver levels of the esterified form of 8-iso-PGF(2alpha), a known in vitro substrate of PAF-AH (II), were higher in Pafah2(-/-) mice than in wild-type mice. These results indicate that PAF-AH (II) is involved in the metabolism of esterified 8-isoprostaglandin F(2alpha) and protects tissue from oxidative stress-induced injury.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
18
pubmed:volume
283
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1628-36
pubmed:meshHeading
pubmed-meshheading:18024956-1-Alkyl-2-acetylglycerophosphocholine Esterase, pubmed-meshheading:18024956-Animals, pubmed-meshheading:18024956-Carbon Tetrachloride, pubmed-meshheading:18024956-Dinoprost, pubmed-meshheading:18024956-Embryo, Mammalian, pubmed-meshheading:18024956-Epithelium, pubmed-meshheading:18024956-Esterification, pubmed-meshheading:18024956-Fibroblasts, pubmed-meshheading:18024956-Gene Targeting, pubmed-meshheading:18024956-Hydrolysis, pubmed-meshheading:18024956-Liver, pubmed-meshheading:18024956-Macrophages, Peritoneal, pubmed-meshheading:18024956-Mice, pubmed-meshheading:18024956-Mice, Knockout, pubmed-meshheading:18024956-Oxidation-Reduction, pubmed-meshheading:18024956-Oxidative Stress, pubmed-meshheading:18024956-Phospholipids, pubmed-meshheading:18024956-Platelet Activating Factor, pubmed-meshheading:18024956-tert-Butyl Alcohol
pubmed:year
2008
pubmed:articleTitle
Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo.
pubmed:affiliation
Graduate School of Pharmaceutical Science, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't